Dr. Qin is a Medical Oncologist with a focus on genitourinary malignancies. She earned her undergraduate degree in Biological Sciences and Asian Studies at Rice University and medical degree at Baylor College of Medicine in Houston. She completed her residency in internal medicine at Houston Methodist Hospital and gained advanced training through a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai in New York.

Dr. Qin returned to Texas and joined UT Southwestern as Eugene P. Frenkel, M.D. Scholar in Clinical Medicine endowed Assistant Professor in the Department of Medicine, Division of Hematology and Medical Oncology. Her clinical specialization includes kidney, prostate, bladder, and testicular cancers and her research goals are to identify novel biomarkers, therapeutics, and therapeutic combinations in the setting of impactful clinical trials. Particularly, her current focus is on novel radiotracer-based biomarkers in genitourinary cancers, where she co-leads investigator initiated clinical trials in this space. Dr. Qin is also leading additional studies in prostate cancer with focuses on the use of PARP inhibitors in patients with homologous recombination repair alterations and kidney cancer with focus on tyrosine kinase inhibitor/immune checkpoint inhibitor combination in the peri-operative setting.